Completion of US-FDA Inspection at Unit-IV, Tarapur of Aarti Pharmalabs Limited

The United States Food and Drug Administration (US FDA) inspected Unit-IV of Aarti Pharmalabs Limited, situated at Plot No. E-50, 50/1, 59/1, MIDC, Tarapur, Tal. & District Palghar, Maharashtra - 401506.

At the end of this inspection which concluded on 27th March 2026, a 'Form 483' was issued with 01 (One) observation. This observation is procedural in nature. The corrective and preventive actions for the observation along with compliance will be submitted to the US FDA within the stipulated period.

Shares of Aarti Pharmalabs Limited was last trading in BSE at Rs. 609.15 as compared to the previous close of Rs. 638.85. The total number of shares traded during the day was 16704 in over 851 trades.

The stock hit an intraday high of Rs. 636.10 and intraday low of 603.05. The net turnover during the day was Rs. 10354495.00.

Source : Equity Bulls

Keywords

AartiPharmalabs INE0LRU01027 Pharmaceuticals USFDA Unit4 Inspection